Article

IntraLase FS30 laser gets 510K approval for penetrating, lamellar corneal resections

Lisbon, Portugal - IntraLase Corp., Irvine, CA, has received 510K clearance from the FDA for use of the IntraLase FS30 femtosecond laser in creating corneal resections performed in lamellar keratoplasty and penetrating keratoplasty (PK) procedures. The IntraLase FS30 laser is the first and only laser to receive clearance for use in PK, according to the manufacturer.

Lisbon, Portugal - IntraLase Corp., Irvine, CA, has received 510K clearance from the FDA for use of the IntraLase FS30 femtosecond laser in creating corneal resections performed in lamellar keratoplasty and penetrating keratoplasty (PK) procedures. The IntraLase FS30 laser is the first and only laser to receive clearance for use in PK, according to the manufacturer.

The company said surgeons can now use the power and precision of the laser to complete resections in a variety of corneal therapeutic applications. The new clearance allows use of the IntraLase FS30 laser to create deep corneal incisions and the full-thickness resections required for PK.

"This really opens up the door for additional uses of this extremely versatile device," said Roger Steinert, MD, of the University of California, Irvine, United States. "In our initial clinical work, we found that the laser has the ability to create shaped, full-thickness corneal transplants that are much stronger than traditional PK transplants with less induction of astigmatism. In addition, transplants created with the laser may require less suturing and faster visual rehabilitation."

IntraLase is developing commercially available software for these new applications as well as a new curved applanation lens to facilitate deep corneal dissections. The laser's current flat applanation lens provides the thin, planar flaps that have recently been shown to improve LASIK outcomes.

For more information, visit IntraLase at Booth #234.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
© 2025 MJH Life Sciences

All rights reserved.